![background image](http://html1.mh-extra.com/html/abbott/precision-xtra/precision-xtra_user-manual_450965060.webp)
Refer
enc
es
References
1. Schade DS, Eaton RP. Metabolic and clinical significance of
ketosis.
Special Topics in Endocrinology and Metabolism
1982;
4:1–27.
2. Wiggam MI, O’Kane MJ, Harper R, Atkinson AB, Hadden DR,
Trimble ER, Bell PM. Treatment of diabetic ketoacidosis using
normalization of blood
3-hydroxybutyrate concentration as the endpoint of emergency
management.
Diabetes Care
1997; 20:1347–52.
3. Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A,
Uno S, Shigeta Y. Ketone bodies as markers for Type 1 (insulin-
dependent) diabetes and their value in the monitoring of
diabetes control.
Diabetologia
1984; 26:343–8.
4. Ubukata E. Diurnal variation of blood
β-Ketone bodies in
insulin-dependent diabetes mellitus and non-insulin-dependent
diabetes mellitus patients: The relationship to serum C-peptide
immunoreactivity and free insulin.
Ann Nutr Metab
1990;
34:333–42.
5. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic
effects of low-dose insulin therapy on glucose metabolism in
diabetic ketoacidosis.
Diabetes
1988; 37:1470–77.
6. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate
in the treatment of diabetic ketoacidosis.
Br Med J
1984;
289; 1035–8.
57